Form 4: GE HealthCare CFO James Saccaro Reports Stock and Option Awards
SEC Form 4 Filing
Chief Financial Officer James Saccaro of GE HealthCare Technologies Inc. reports the acquisition of restricted stock units and employee stock options.
Summary
- On March 3, 2025, James Saccaro, the CFO of GE HealthCare Technologies Inc., reported transactions involving the company's stock.
- Saccaro was awarded 11,278 restricted stock units (RSUs) and an employee stock option for 32,252 shares.
- The RSUs will vest in three tranches: 33% on September 3, 2026, 33% on September 3, 2027, and 34% on September 3, 2028.
- The employee stock options, with an exercise price of $86.45, will become exercisable in similar tranches on the same dates as the RSUs.
- Following these transactions, Saccaro beneficially owns 71,544 shares of GE HealthCare common stock and options for 32,252 shares.
- The report was filed on March 5, 2025, by Frank R. Jimenez, General Counsel and Corporate Secretary, as attorney-in-fact.
Sentiment
Score: 7
Explanation: The sentiment is neutral to positive. The document simply reports standard executive compensation practices, which are generally viewed favorably as they align management and shareholder interests.
Positives
- The granting of stock options and restricted stock units to the CFO aligns his interests with those of the shareholders.
- The vesting schedule encourages long-term commitment and performance.
Industry Context
Stock and option awards are a common practice in the healthcare industry to incentivize and retain key executives. These awards align management's interests with those of shareholders, encouraging long-term value creation.
Comparison to Industry Standards
- Executive compensation packages, including stock options and restricted stock units, are standard practice among publicly traded companies, including GE HealthCare's competitors such as Siemens Healthineers and Philips.
- The vesting schedules are also typical, designed to retain executives and align their interests with long-term shareholder value.
Stakeholder Impact
- Shareholders may view the stock and option awards positively as they incentivize management to improve company performance.
- Employees may see this as a positive sign of the company's commitment to its leadership.
Key Dates
| Date | Description |
|---|---|
| 03/03/2025 | Date of the reported transactions (award of RSUs and stock options). |
| 03/05/2025 | Date the Form 4 was filed. |
| 09/03/2026 | First vesting date for 33% of the RSUs and stock options. |
| 09/03/2027 | Second vesting date for 33% of the RSUs and stock options. |
| 09/03/2028 | Final vesting date for 34% of the RSUs and stock options. |
| 03/03/2035 | Expiration date of the employee stock options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.